論文
２０１１年
Goto N, Hiyoshi H, Ito I, Tsuchiya M, Nakajima Y, Yanagisawa J.
Estrogen and antiestrogens alter breast cancer invasiveness by modulating the transforming growth factor-β signaling pathway.
Kumazawa T, Nishimura K, Kuroda T, Ono W, Yamaguchi C, Katagiri N, Tsuchiya M, Masumoto H, Nakajima Y, Murayama A, Kimura K, Yanagisawa J.
Novel Nucleolar Pathway Connecting Intracellular Energy Status with p53 Activation.
J Biol Chem. 2011 Jun 10;286(23):20861-9.
Nakajima Y, Akaogi K, Suzuki T, Osakabe A, Yamaguchi C, Sunahara N, Ishida J, Kako K, Ogawa S, Fujimura T, Homma Y, Fukamizu A, Murayama A, Kimura K, Inoue S, Yanagisawa J.
Estrogen Regulates Tumor Growth Through a Nonclassical Pathway that Includes the Transcription Factors ERβ and KLF5.
Sci Signal. 2011 Apr 12;4(168):ra22.
Tsuchiya M, Katagiri N, Kuroda T, Kishimoto H, Nishimura K, Kumazawa T, Iwasaki N, Kimura K, Yanagisawa J.
Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint.
Biochem Biophys Res Commun. 2011 Mar 17.
Kuroda T, Murayama A, Katagiri N, Ohta Y, Fujita E, Masumoto H, Ema M, Takahashi S, Kimura K, Yanagisawa J.
RNA content in the nucleolus alters p53 acetylation via MYBBP1A.
The EMBO Journal, 2011, 30, 1054-1066.
２０１０年
Ito I, Hanyu A, Wayama M, Goto N, Katsuno Y, Kawasaki S, Nakajima Y, Kajiro M, Komatsu Y, Fujimura A, Hirota R, Murayama A, Kimura K, Imamura T, Yanagisawa J.
Estrogen inhibits TGF-β signaling by promoting Smad2/3 degradation.
J. Biol. Chem., 2010, 285 (19), 14747-55.
２００９年
Takemoto A, Maeshima K, Ikehara T, Yamaguchi K, Murayama A, Imamura S, Imamoto N, Yokoyama S, Hirano T, Watanabe Y, Hanaoka F, Yanagisawa J, Kimura K.
The chromosomal association of condensin II is regulated by a noncatalytic function of PP2A.
Nature Structural & Molecular Biology, Published online November 15 2009
Mikogai A, Yanagisawa J, Yasuzawa-Tanaka K, Murayama A.The nucleolar protein NML regulates hepatic ATP levels during liver regeneration after partial hepatectomy.
Biochem Biophys Res Commun. 2009 Oct 9.
Akaogi K, Nakajima Y, Ito I, Kawasaki S, Oie S, Murayama A, Kimura K, Yanagisawa J.
KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ER alpha
Oncogene. 2009 June 8.
Kajiro M, Hirota R, Nakajima Y, Kawanowa K, So-ma K, Ito I, Yamaguchi Y, Ohie S, Kobayashi Y, Seino Y, Kawano M, Kawabe YI, Takei H, Hayashi S, Kurosumi M, Murayama A, Kimura K, Yanagisawa J.
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways.
Nature Cell Biology 2009 Mar;11(3):312-9.
２００８年
Ema M, Mori D, Niwa H, Hasegawa Y, Yamanaka Y, Hitoshi S, Mimura J, Kawabe Y, Hosoya T, Morita M, Shimosato D, Uchida K, Suzuki N, Yanagisawa J, Sogawa K, Rossant J, Yamamoto M, Takahashi S, Fujii-Kuriyama Y.
Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs.
Cell Stem Cell. 2008 Nov 6;3(5):555-67.
Akiko Murayama, Kazuji Ohmori, Akiko Fujimura, Hiroshi Minami, Kayoko Yasuzawa-Tanaka, Takao Kuroda, Shohei Oie, Hiroaki Daitoku, Mitsuru Okuwaki, Kyosuke Nagata, Akiyoshi Fukamizu, Keiji Kimura, Toshiyuki Shimizu and Junn Yanagisawa
Epigenetic Control of rDNA Loci in Response to Intracellular Energy Status
Cell, Volume 133, Issue 4, 16 May 2008, Pages 627-639
Komatsu Y, Ito I, Wayama M, Fujimura A, Akaogi K, Machida H, Nakajima Y, Kuroda T, Ohmori K, Murayama A, Kimura K, Yanagisawa J.
PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Biochem Biophys Res Commun. 2008 May 23;370(1):145-8. Epub 2008 Mar 18
２００７年
Takemoto A, Katano M, Urano T, Furukawa K, Yokoyama S, Yanagisawa J, Hanaoka F and Kimura K
Analysis of the role of Aurora B on the chromosomal targeting of condensing I
Nucleic Acids Res. 2007, vol.35, No.7 2403-2412
２００６年
Takemoto A, Kimura K (Co-corresponding author), Yanagisawa J, Yokoyama S, Hanaoka F.
Negative regulation of condensing I by CK2-mediated phosphorylation.
EMBO J. 2006 25, 5339-5348.
Tateishi Y, Sonoo R, Sekiya Y, Sunahara N, Kawano M, Wayama M, Hirota R, Kawabe Y, Murayama A, Kato S, Kimura K, Yanagisawa J.
Turning Off Estrogen Receptor β-Mediated Transcription Requires Estrogen-Dependent Receptor Proteolysis.
Molecular and Cellular Biology 26.21(2006): 7966-7976.
Murayama A, Sakura K, Nakama M, Yasuzawa-Tanaka K, Fujita E, Tateishi Y, Wang Y, Ushijima T, Shibuya K, Kawabe Y, Yanagisawa J.
A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory.
EMBO J. 2006 25: 1081-1092.
Oishi H, Kitagawa H, Wada O, Takezawa S, Tora L, Kouzu-Fujita M, Takada I, Yano T, Yanagisawa J, Kato S.
An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification.
J Biol Chem. 281 (1): 20-26 JAN 6 2006.
２００５年
Ogawa S, Oishi H, Mezaki Y, Kouzu-Fujita M, Matsuyama R, Nakagomi M, Mori E, Murayama E, Nagasawa H, Kitagawa H, Yanagisawa J, Yano T, Kato S.
Repressive domain of unliganded human estrogen receptor alpha associates with Hsc70.
Genes Cells. 2005 Dec;10(12):1095-102.
Masuhiro Y, Mezaki Y, Sakari M, Takeyama K, Yoshida T, Inoue K, Yanagisawa J, Hanazawa S, O'malley BW, Kato S.
Splicing potentiation by growth factor signals via estrogen receptor phosphorylation.
Proc Natl Acad Sci USA. 2005 Jun 7;102(23):8126-31
Unno A, Takada I, Takezawa S, Oishi H, Baba A, Shimizu T, Tokita A, Yanagisawa J, Kato S.
TRRAP as a hepatic coactivator of LXR and FXR function.
Biochem. Biophys. Res. Commun. 2005 Feb 18;327(3):933-8
２００４年
Tateishi Y, *Kawabe Y(*co-first author), Chiba T, Murata S, Ichikawa K, Murayama A, Tanaka K, Baba T, Kato S, Yanagisawa J.
Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
EMBO J. 2004 23:4813-4823
Iwase S, Januma A, Miyamoto K, Shono N, Honda A, Yanagisawa J, Baba T.
Characterization of BHC80 in BRAF-HDAC complex, involved in neuron-specific gene repression.
Biochem. Biophys. Res. Commun. 2004 Sep 17;322(2):601-8
Wada O, Oishi H, Takada I, Yanagisawa J, Yano T, Kato S.
BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220.
Oncogene. 2004 Jun 21
Murayama A, Kim MS, Yanagisawa J, Takeyama KI, Kato S.
Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.
EMBO J. 2004 23:1598-1608
Kahata K, Hayashi M, Asaka M, Hellman U, Kitagawa H, Yanagisawa J, Kato S, Imamura T, Miyazono K.
Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5.
Genes Cells 2004 Feb;9(2):143-51.
Fan W, Yanase T, Wu Y, Kawate H, Saitoh M, Oba K, Nomura M, Okabe T, Goto K, Yanagisawa J, Kato S, Takayanagi R, Nawata H.
Protein kinase A potentiates adrenal 4 binding protein/steroidogenic factor 1 transactivation by reintegrating the subcellular dynamic interactions of the nuclear receptor with its cofactors, general control nonderepressed-5/transformation/transcription domain-associated protein, and suppressor, dosage-sensitive sex reversal-1: a laser confocal imaging study in living KGN cells.
Mol.Endocrinol. 2004 Jan;18(1):127-41.
２００３年
Yamamoto Y, Wada O, Takada I, Yogiashi Y, Shibata J, Yanagisawa J, Kitazato K, Kato S.
Both N- and C-terminal transactivation functions of DNA-bound ERalpha are blocked by a novel synthetic estrogen ligand.
Biochem.Biophys.Res.Commun. 2003 Dec 19;312(3):656-62.
Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe YI, Yanagisawa J.
Full activation of estrogen receptor alpha (ER alpha) activation function-1 (AF-1) induces proliferation of breast cancer cells.
J.Biol.Chem. 2003 Jul 18;278(29):26704-26714.
Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J, Kato S.
The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome.
Cell 2003 Jun 27;113(7):905-17.
Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y, Kato S.
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.
Nature 2003 May 29;423(6939):545-50
Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, Yamauchi T, Kadowaki T, Takeuchi Y, Shibuya H, Gotoh Y, Matsumoto K, Kato S.
Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade.
Nature.Cell.Biol. 2003 Mar,5(3):224-30.
２００２年
Hardy S, Brand M, Mittler G, Yanagisawa J, Kato S, Meisterernst M, Tora L.
TATA-binding Protein-free TAF-containing Complex (TFTC) and p300 Are Both Required for Efficient Transcriptional Activation.
J.Biol.Chem. 2002 Sep 6;277(36):32875-32882.
Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S.
Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.
Mol.Cell.Biol. 2002 Jun;22(11):3698-706
Yanagisawa, J., Kitagawa, H., Yanagida, M., Wada, O., Ogawa, S., Nakagomi, M.,Oishi,H., Yamamoto, Y., McMahon, S. B., Cole, M. D., Tora L., Takahashi, N., Nagasawa, H., Kato, S.
Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex.
Mol.Cell. 2002 Mar;9(3):553-62.
Nawata H, Goto K, Morinaga H, Yanase T, Yanagisawa J, Kato S, Nomura M, Okabe T, Takayanagi R.
Molecular mechanisms underlying the action of environmental endocrine-disrupting chemicals
Environmental Science 2002 9, 1 :057-070 2002
２００１年
Mezaki Y, Yoshida T, Yanagisawa J, Kato S.
N-terminal activation function is dominant in ligand-dependent transactivation of medaka estrogen receptor alpha in human cells.
Biochem.Biophys.Res.Commun. 2001 Dec 7;289(3):763-8.
Yamamoto Y, Wada O, Suzawa M, Yogiashi Y, Yano T, Kato S, Yanagisawa J
The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes..
J. Biol. Chem. 2001 Nov 16;276(46):42684-91.
Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S.
A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.
EMBO J. 2001 Mar 15;20(6):1341-52.
２０００年
Kato S, Masuhiro Y, Watanabe M, Kobayashi Y, Takeyama KI, Endoh H, Yanagisawa J.
Molecular mechanism of a cross-talk between oestrogen and growth factor signalling pathways.
Genes Cells. 2000 Aug;5(8):593-601.
Kobayashi Y, Kitamoto T, Masuhiro Y, Watanabe M, Kase T, Metzger D, Yanagisawa J, Kato S.
p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
J.Biol.Chem. 2000 May 26;275(21):15645-51.
Yanagi Y, Masuhiro Y, Mori M, Yanagisawa J, Kato S.
p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor.
Biochem.Biophys.Res.Commun. 2000 Mar 16;269(2):410-4.
それ以前
Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S.
Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.
Mol.Cell.Biol. 1999 Aug;19(8):5363-72.
Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J, Kato S.
Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins.
J. Biol. Chem. 1999 May 7;274(19):12971-4.
Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S.
Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.
Science 1999 Feb 26;283(5406):1317-21.
Takeyama K, Masuhiro Y, Fuse H, Endoh H, Murayama A, Kitanaka S, Suzawa M, Yanagisawa J, Kato S.
Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog.
Mol.Cell.Biol. 1999 Feb;19(2):1049-55.
Kato S, Kitamoto T, Masuhiro Y, Yanagisawa J.
Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways.
Oncology. 1998 Dec;55 Suppl 1:5-10.
Nishihara A, Hanai JI, Okamoto N, Yanagisawa J, Kato S, Miyazono K, Kawabata M.
Role of p300, a transcriptional coactivator, in signalling of TGF-beta.
Genes Cells. 1998 Sep;3(9):613-23.
Kato S, Yanagisawa J, Murayama A, Kitanaka S, Takeyama K.
The importance of 25-hydroxyvitamin D3 1 alpha-hydroxylase gene in vitamin D-dependent rickets.
Curr.Opin.Nephrol.Hypertens. 1998 Jul;7(4):377-83.
Watanabe M, Yanagi Y, Masuhiro Y, Yano T, Yoshikawa H, Yanagisawa J, Kato S.
A putative tumor suppressor, TSG101, acts as a transcriptional suppressor through its coiled-coil domain.
Biochem.Biophys.Res.Commun. 1998 Apr 28;245(3):900-5.
Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S.
Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.
N.Engl.J.Med. 1998 Mar 5;338(10):653-61.
Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S.
25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis.
Science. 1997 Sep 19;277(5333):1827-30.
Yanagisawa J, Takahashi M, Kanki H, Yano-Yanagisawa H, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S, Sato T.
The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis.
J.Biol.Chem. 1997 Mar 28;272(13):8539-45.
Yanagisawa J, Tsuda M, Ohkubo T, Hiyoshi M, Kamiguchi H, Tsukamoto H, Yamamura M, Kocha T, Aoyagi T.
A new type of major aminopeptidase in bovine brain.
Biochem.Mol.Med. 1996 Dec;59(2):161-8
Tada S, Yanagisawa J, Sonoyama T, Miyajima A, Seki M, Ui M, Enomoto T.
Characterization of the properties of a human homologue of Escherichia coli RecQ from xeroderma pigmentosum group C and from HeLa cells.
Cell Struct Funct 1996 Apr;21(2):123-32
Yanagisawa J, Ando J, Nakayama J, Kohwi Y, Kohwi-Shigematsu T.
A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues.
Cancer Res. 1996 Feb 1;56(3):457-62
Inazawa J, Ariyama T, Abe T, Druck T, Ohta M, Huebner K, Yanagisawa J, Reed JC, Sato T.
PTPN13, a fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3.
Genomics 1996 Jan 15;31(2):240-2
Seki M, Kohda T, Yano T, Tada S, Yanagisawa J, Eki T, Ui M, Enomoto T.
Characterization of DNA synthesis and DNA-dependent ATPase activity at a restrictive temperature in temperature-sensitive tsFT848 cells with thermolabile DNA helicase B.
Mol.Cell.Biol. 1995 Jan;15(1):165-72
Seki M, Miyazawa H, Tada S, Yanagisawa J, Yamaoka T, Hoshino S, Ozawa K, Eki T, Nogami M, Okumura K, et al.
Molecular cloning of cDNA encoding human DNA helicase Q1 which has homology to Escherichia coli Rec Q helicase and localization of the gene at chromosome 12p12.
Nucleic Acids Res. 1994 Nov 11;22(22):4566-73
Masutani C, Sugasawa K, Yanagisawa J, Sonoyama T, Ui M, Enomoto T, Takio K, Tanaka K, van der Spek PJ, Bootsma D, et al.
Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23.
EMBO J. 1994 Apr 15;13(8):1831-43
Seki M, Yanagisawa J, Kohda T, Sonoyama T, Ui M, Enomoto T.
Purification of two DNA-dependent adenosinetriphosphatases having DNA helicase activity from HeLa cells and comparison of the properties of the two enzymes.
J.Biochem. (Tokyo) 1994 Mar;115(3):523-31
Yanagisawa J, Seki M, Kohda T, Enomoto T, Ui M.
DNA-dependent adenosinetriphosphatase C1 from mouse FM3A cells has DNA helicase activity.
J.Biol.Chem. 1992 Feb 25;267(6):3644-9
Yanagisawa J, Seki M, Ui M, Enomoto T.
Alteration of a DNA-dependent ATPase activity in xeroderma pigmentosum complementation group C cells.
J.Biol.Chem. 1992 Feb 25;267(6):3585-8
Seki M, Enomoto T, Yanagisawa J, Hanaoka F, Ui M.
Further characterization of DNA helicase activity of mouse DNA-dependent adenosinetriphosphatase B (DNA helicase B).
Biochemistry 1988 Mar 8;27(5):1766-71
総説
エストロゲンレセプターと癌
伊藤一明、神代理史、小松蓉子、柳澤純
ゲノム医学（ケミカルレビュー社） 2008 8巻、1号
DNA脱メチル化と遺伝子応答
村山明子 柳澤純
実験医学 羊土社 vol.25 No.10 p.124 2007
ユビキチンシステムによる核内受容体の転写制御機構
川辺洋一、神代理史、片野幸、柳澤純
実験医学 羊土社 vol.24 No.10 p.122 2006
RNAiによるDNAのメチル化制御機構
佐倉和久、村山明子、柳澤純
実験医学 羊土社 vol.24 No.3 p.328 2006
ガン遺伝子ｃ－ｍｙｃは核小体でｒRNA合成を亢進する
村山明子 柳澤純
実験医学 羊土社 vol.23 No.13 p.2027 2005
厳選辞書シリーズ 転写 羊土社
村山明子 柳澤純
第Ⅱ部 カテゴリー６ 核内受容体
エストロゲンレセプター（ER）と乳癌
柳澤 純
ステロイドホルモン研究の進歩2003
ホルモンと臨床 第52巻 冬季増刊号 Vol.52 75-82. 2004
転写複合体の新展開
柳澤 純
生化学 Vol.76 No.1 37-41. 2004
乳癌の増殖におけるエストロゲンおよびそのレセプターの新知見
柳澤 純
Biotherapy Vol. 16 No.5, 2003
転写制御機構のプロテオミクス
柳澤 純、加藤茂明
プロテオミクス最前線 実験医学増刊号 2002
エストロゲンレセプター(ER)の新規転写活性化因子複合体の同定と解析
柳澤 純、北川浩史、和田 修、中込円、小川智子、加藤茂明
ステロイドホルモン研究の進歩 2002
柳澤 純、北川浩史、小川智子、和田 修、山本泰司、加藤茂明
癌の臨床 ４７, 799-806, 2002
核内レセプターによる転写制御の分子メカニズム
柳澤 純、加藤茂明
Molecular Medicine, 39, 254-262, 2002
ホルモン結合ドメイン
柳澤 純、加藤茂明
生体の科学 52, 390-391, 2001
ＴＧＦβとビタミンＤシグナル伝達機構の共通性
柳澤 純、柳 靖雄、加藤茂明
臨床免疫 34,83-90,2000
ビタミンＤとＴＧＦ-β
柳 靖雄、柳澤 純、加藤茂明
内分泌・糖尿病科,10,357-365,2000
性ステロイドレセプターによる転写制御の分子メカニズム
柳澤 純、渡辺理子、加藤茂明
遺伝子医学,4,165-169,2000
リガンド依存的な核内レセプター転写制御の分子メカニズム
柳澤 純、渡辺理子、小林陽子、加藤茂明
実験医学,18,229-234,2000
核内レセプターの転写共役因子
柳澤 純、舛広善和、加藤茂明
医学のあゆみ,186,657-662,1998
細胞増殖因子と核内レセプターとのシグナルクロストークの分子メカニズム
柳澤 純、柳 靖雄、舛広善和、加藤茂明
実験医学,16,2436-2442,1998
特許
NRDF
特願2004-42169
「核内受容体分解抑制物質又は核内受容体分解促進物質のスクリーニング方法」
出願日：平成16年2月18日
出願人：株式会社インテライト
発明者：柳澤純、川辺洋一
CHIP
特願2004-47126
「核内受容体分解抑制物質又は核内受容体分解促進物質のスクリーニング方法」
出願日：平成16年2月23日
出願人：株式会社インテライト
発明者：柳澤純、立石幸代
受賞
小松蓉子，後藤夏華．10’ 遺伝情報DECODE冬のワークショップ，DECODE賞，湯沢，2010.1.21.柳澤明子，柳澤純．若手科学者賞，科学技術分野文部科学大臣表彰，2009.4.14.
柳澤純．第5回日本学術振興会賞，独立行政法人日本学術振興会，2009.3.9.
柳澤純．筑波大学賞，筑波大学，2009.2.19.
仲島由佳，柳澤純．第9回関東ホルモンと癌研究会，研究奨励賞，東京，2009.1.24.
神代理史，川崎祥平，柳澤純．09’ 遺伝情報DECODE冬のワークショップ，DECODE賞，湯沢，2009.1.21.
大森一二，柳澤純．Keystone Symposia Scholarship，Colorado, 2008.3.30-2008.4.4.
小松蓉子，柳澤純．08’ 遺伝情報DECODE冬のワークショップ，DECODE賞，湯沢，2008.1.23.
伊藤一明，柳澤純．第8回関東ホルモンと癌研究会，研究奨励賞，東京，2008.1.19.
ページTOPに戻る
